(Q73185913)
Statements
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion (English)
G J Martin
S D Boden
2188-93; discussion 2193-4